For years, diabetes care has relied on one key rule: insulin should be given before meals whenever possible. Yet many people living with diabetes still struggle with timing. Busy schedules, unpredictable eating habits, and delayed dosing often lead to postprandial glucose spikes. Now, with the rise of ultra-rapid insulin AID …
Read More »Smart Insoles and AI Foot Monitoring: Could Diabetes Foot Care Finally Become Preventive?
For many people living with diabetes, foot complications often begin quietly. A small pressure point, unnoticed inflammation, or minor skin breakdown can slowly develop into a serious ulcer. Unfortunately, traditional diabetic foot care has long been reactive. Clinicians typically intervene after visible wounds appear, when treatment becomes more difficult and …
Read More »The New Pregnancy Tech Era in Diabetes: How Automated Insulin Delivery Is Expanding Into Maternal Care
The management of type 1 diabetes during pregnancy is entering a major turning point. For years, endocrinologists and maternal-fetal medicine specialists have worked within narrow therapeutic margins to reduce maternal and neonatal complications. However, new advances in automated insulin delivery technology for pregnancy are beginning to reshape glucose management in …
Read More »Is Carb Counting Becoming Obsolete? The Rise of Precision Nutrition in Diabetes Care
A bowl of oatmeal can keep one person’s glucose stable while sending another person’s blood sugar sharply upward. The meal is identical, yet the metabolic response is completely different. That reality is pushing many clinicians to reconsider one of the most established principles in diabetes nutrition: carb counting. The growing …
Read More »Automated Insulin Delivery Is Expanding Into Type 2 Diabetes: Are Primary Care Practices Ready?
Automated insulin delivery for people with type 2 diabetes is entering a new phase. What once seemed reserved for highly specialized endocrinology clinics is now moving steadily into primary care offices across the country. Following the updated 2026 American Diabetes Association Standards of Care and recent FDA clearances, more adults …
Read More »Diabetes Burnout Is Rising in the Age of Always-On Technology
A glucose alarm goes off during dinner. Another alert appears at 2 a.m. A smartphone app flashes warnings about rising blood sugar before the day even starts. Diabetes technology promises better control, yet for some patients, the nonstop stream of notifications and health data can feel mentally exhausting. Clinicians are …
Read More »Are Wearables Redefining Prediabetes — or Over-Medicalizing It?
Prediabetes has traditionally been diagnosed during annual physical exams through fasting glucose tests or A1C measurements. However, new diabetes prevention tools and wearable technologies are rapidly changing that model. Today, wearable devices, continuous glucose monitors (CGMs), and predictive metabolic tracking tools are giving people real-time insight into their glucose patterns …
Read More »Why Early Combination Therapy Is Gaining Momentum in Young-Onset Type 2 Diabetes
Young adults diagnosed with type 2 diabetes early in life often face a more aggressive disease course than older adults. While metformin has long served as the standard first-line therapy, many clinicians are now reconsidering whether a “metformin-first and wait” strategy is enough for this higher-risk population. As research continues …
Read More »Can AI Eye Exams Expand Diabetic Retinopathy Screening Access?
Diabetic retinopathy remains one of the leading causes of preventable blindness worldwide. Yet despite clear screening guidelines, many patients with diabetes still miss their annual retinal exams. Busy schedules, limited specialist access, transportation barriers, and lack of awareness often delay diagnosis until vision changes become permanent. As healthcare systems search …
Read More »Cancer Therapy Is Changing Diabetes Management: What Clinicians Need to Know Now
Cancer treatment is evolving rapidly, and with that progress comes a new challenge for clinicians managing glucose disorders. As immune checkpoint inhibitors (ICIs) and PI3K inhibitors become more widely used in oncology, therapy-related hyperglycemia is appearing more often in clinical practice. Many patients receiving cancer treatment now face unexpected glucose …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.